|
Sign up
|
|
Automatic website change logs and notification
|
|
|
|
|
|
|
|
|
|
|
|
|
XOMA
Current status: normal - monitoring
Number of users monitoring this page: 0
Most recent sizable change (text, html) : 2013-05-09 10:28
Most recent change (text, html) : 2013-05-09 10:28
Last checked for changes: 2013-05-18 10:28
ChangeDetection started monitoring: 2008-02-04 10:28
|
|
|
monitor this page
summary of most recent changes
|
View changes:
2013-05-09 10:28
5 new words, 19 deleted words, 15% change
|
|
... expanded development program: Phase 2 POC Moderate to ... Acne Vulgaris Study Results Slides Current Corporate Presentation 2012 FY/Q4 conference call and webcast 1 2013 Conference Call Webcast © 2012 XOMA.
expanded development program: ... Q1 2013 Conference Call Webcast © 2012 XOMA.
expanded development program: Phase 2 POC Moderate to ... Acne Vulgaris Study Results Slides Current Corporate Presentation 2012 FY/Q4 conference call and webcast © 2012 XOMA.
more...
|
|
View changes:
2013-04-02 10:28
0 new words, 2 deleted words, 1% change
|
|
... Slides Current Corporate Presentation Press release 2012 FY/Q
Slides Current Corporate Presentation ... 2012 FY/Q
Slides Current Corporate Presentation Press release 2012 FY/Q
|
|
View changes:
2013-03-12 17:26
5 new words, 1 deleted words, 3% change
|
|
... Corporate Presentation Press release Replay 2012 FY/Q4 conference call and webcast
Corporate Presentation Press release 2012 FY/Q4 conference call and webcast
Corporate Presentation Press release Replay conference call and webcast
|
|
View changes:
2013-01-07 10:50
19 new words, 8 deleted words, 16% change
|
|
... expanded development program: Replay conference call and webcast Phase 2 POC Moderate to Severe Acne Vulgaris Study Results Slides Current Corporate Presentation Press release Current Corporate Presentation Replay conference call and webcast © 2012 XOMA.
expanded development program: Phase 2 POC Moderate to Severe Acne Vulgaris Study Results Slides Current Corporate Presentation Press release Replay conference call and webcast © 2012 XOMA.
expanded development program: Replay conference call and webcast Press release Current Corporate Presentation © 2012 XOMA.
|
|
View changes:
2012-02-22 11:19
13 new words, 9 deleted words, 14% change
|
|
... and process development. BIO CEO and Investor Conference 2012 PresentationGevokizumab expanded development program: BIO 2012 Replay conference call and webcast Press release Current Corporate Presentation © 2011 XOMA
and process development. Gevokizumab expanded development program: Replay conference call and webcast Press release Current Corporate Presentation © 2011 XOMA
and process development. BIO CEO and Investor Conference 2012 Presentation: BIO 2012 Presentation © 2011 XOMA
|
link to this change log
Changes to the page www.xoma.com are logged on this page as they are detected. You can link to this log
by pasting the HTML below into your page. It produces a link which looks like this: change log
|
|
|
Automatic website change logs and notification
|
|
|
|
|
|
|
|
|
|
|
Copyright 1999-2010 FreeFind.com.
ChangeDetection and ChangeDetection.com are trademarks of FreeFind.com.
|
|
home
faq
policies
contact
website panels
tag reference
Site search technology provided by FreeFind.com and Findia.Net net search
|